Americas (WHO region) vs Latvia: Hib (Hib3) immunization coverage among 1-year-olds (%)
Americas (WHO region)
86.0%
in 2025
Latvia
99.0%
in 2025
Americas (WHO region) rank
4th
Latvia rank
1st
Hib (Hib3) immunization coverage among 1-year-olds (%) over time
- Americas (WHO region)
- Latvia
How they compare
Latvia currently reports 99.0% against 86.0% in Americas (WHO region), a difference of 13.0%.
That makes Latvia's figure about 1.2 times Americas (WHO region)'s.
The two have swapped places 2 times across 26 shared years of data; in 2000 it was Latvia ahead.
Americas (WHO region) ranks 4th and Latvia ranks 1st of 11 groups.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Americas (WHO region) | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 86.4% | 92.1% | 5.7% | Latvia |
| 2010s | 89.3% | 94.2% | 4.9% | Latvia |
| 2020s | 83.5% | 96.8% | 13.3% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hib (hib3) immunization coverage among 1-year-olds (%), Americas (WHO region) or Latvia?
- Latvia, at 99.0% against 86.0% in Americas (WHO region) as of 2025.
- What is the difference in hib (hib3) immunization coverage among 1-year-olds (%) between Americas (WHO region) and Latvia?
- 13.0%, with Latvia ahead.
- How many years of comparable data are there for Americas (WHO region) and Latvia?
- 26 years are reported by both, from 2000 to 2025.
- How do Americas (WHO region) and Latvia rank globally for hib (hib3) immunization coverage among 1-year-olds (%)?
- Americas (WHO region) ranks 4th and Latvia ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hib (Hib3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.